Oral Administration of Recombinant Adeno-Associated Virus Elicits Human Immunodeficiency Virus-Specific Immune Responses
- 1 September 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (13) , 1571-1581
- https://doi.org/10.1089/10430340260201662
Abstract
Oral vaccines can induce both systemic and mucosal immunity. Mucosal immunity, especially regional cell-mediated immunity, plays an important role in protecting individuals from infectious diseases such as acquired immunodeficiency syndrome. In this study, a recombinant adeno-associated virus vector expressing human immunodeficiency virus type 1 env gene (AAV-HIV) was orally administered to BALB/c mice. Systemic and regional immunity was induced in the mice. Furthermore, the immunization significantly reduced viral load after an intrarectal challenge with a recombinant vaccinia virus expressing HIV env gene. Moreover, we also show that dendritic cells might contribute to the AAV-HIV vector-induced immune responses.Keywords
This publication has 45 references indexed in Scilit:
- Adeno-Associated Virus Type 2-Mediated Transduction of Human Monocyte-Derived Dendritic Cells: Implications for Ex Vivo ImmunotherapyJournal of Virology, 2001
- A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency VirusHuman Gene Therapy, 2001
- Detection of progeny immune responses after intravenous administration of DNA vaccine to pregnant miceBiological Procedures Online, 2001
- The effects of DNA containing CpG motif on dendritic cellsImmunology, 2000
- Recombinant Adeno-Associated Virus-Mediated Correction of Lysosomal Storage within the Central Nervous System of the Adult Mucopolysaccharidosis Type VII MouseHuman Gene Therapy, 2000
- An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and EpilepsyScience, 2000
- Induction of Immunity to Antigens Expressed by Recombinant Adeno-Associated Virus Depends on the Route of AdministrationClinical Immunology, 1999
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Intestinal antibody responses to oral vaccination in HIV-infected individualsAIDS, 1993
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991